Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Lenvabuzz 4mg Capsule
Manufacturer/Marketed By : JASGUR LIFE SCIENCES LLP
$15.92 $10.99
Sidmex Inovia offers bulk export supply of Lenvabuzz 4mg Capsule (LENVATINIB) for hospitals, distributors and tender buyers. Request a quote with your quantity and destination country.Documents, cold-chain shipping and tenders:...
LENVATINIB
Active Pharmaceutical Ingredient
Lenvabuzz 4mg Capsule
$15.92
$10.99
Sidmex Inovia offers bulk export supply of Lenvabuzz 4mg Capsule (LENVATINIB) for hospitals, distributors and tender buyers. Request a quote with your quantity and destination country.
Documents, cold-chain shipping and tenders: see our Export FAQ.
Priority markets: Philippines, United Arab Emirates, Kenya, Egypt, Brazil. We also export worldwide, including:
Middle East: United Arab Emirates, Saudi Arabia, Oman, Qatar, Kuwait, Bahrain, Iraq, Jordan, Lebanon, Yemen, Turkey
Africa: Egypt, Algeria, Morocco, Libya, Nigeria, Ghana, Benin, Burkina Faso, Côte d'Ivoire, Gambia, Kenya, Tanzania, Rwanda, Ethiopia, Djibouti, Somalia, South Africa, Zimbabwe, Mauritius
Asia: Sri Lanka, Bangladesh, Nepal, Maldives, Philippines, Vietnam, Laos, Malaysia, Thailand, Singapore, Taiwan
CIS & Eastern Europe: Russia, Kazakhstan, Uzbekistan, Azerbaijan, Georgia, Serbia, Latvia
Latin America & Caribbean: Mexico, Brazil, Chile, Peru, Colombia, Bolivia, Dominican Republic, Bahamas, Barbados
Europe & Other: Switzerland, United Kingdom, Canada
Related products we supply: Alburel 20 gm/100 ml Injection
Lenvabuzz 4mg Capsule is an anticancer drug belonging to the category of tyrosine kinase inhibitors. It contains the active ingredient Lenvatinib. It is used to treat advanced thyroid cancer in individuals who have not responded to radioactive iodine treatment. It is also used to treat hepatocellular carcinoma. It can be used with other anticancer medications to treat endometrial carcinoma, a kind of advanced uterine cancer. It is also used in combination with other anticancer drugs to treat renal cell carcinoma. Lenvabuzz 4mg Capsule is not recommended for patients with hypersensitivity or allergic to the active compound and its constituents. It is not recommended for use in children and adolescents below 18 years. It is recommended to maintain an optimal blood pressure during the therapy and not recommended for patients with grade 3 and grade 4 hypertension. It is not recommended for patients with grade 3 and 4 hepatotoxicity and renal failure. You are advised to monitor your liver and kidney function during the therapy. It is recommended to consult your healthcare provider and stop Lenvabuzz 4mg Capsule before any scheduled surgery and it is advised not to administer for at least 2 weeks after major surgery or until the wound has healed properly. Tell your physician if you suspect pregnancy, breastfeeding, or planning to have a baby. It is not recommended to take Lenvabuzz 4mg Capsule during pregnancy or breastfeeding as it may harm your baby. It is advised to use effective contraception during the treatment and one month following the completion of therapy. Consult your doctor for contraceptive measures to be taken. Consult your dentist before taking Lenvabuzz 4mg Capsule, which might decrease wound healing and increase the risk of bleeding. It is necessary to inform your physician about all the drugs you are taking including herbal and vitamin supplements.
Active Pharmaceutical Ingredient
Uses
• Differentiated thyroid cancer
• Renal cell carcinoma
• Hepatocellular carcinoma
• Endometrial carcinoma
Benefits
Lenvabuzz 4mg Capsule inhibits the enzyme receptor tyrosine kinase (RTK). RTKs create new blood vessels that give oxygen and nutrients to cells and promote their growth. This medication blocks the receptors that promote the formation of blood vessels in tumor cells. RTKs are found in large numbers in cancer cells, and administering this drug lowers the rate of growth and multiplication.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.
Most Common Side Effects
• High or low Blood pressure
• Loss of appetite
• Nausea, vomiting, constipation, diarrhea or indigestion
• Tiredness
• Hoarse voice
• Leg swelling
• Rashes
• Pain in joints or muscles
• Hair loss
• Sleeplessness
• Protein in urine, frequent urination
• Low potassium, magnesium and calcium levels in the blood
• Dehydration
• Skin problems
• Gallbladder inflammation
• Increase in the values of cholesterol, thyroid-stimulating hormone, digestive enzymes
• Delayed wound healing
Common Side Effects
• Chest pain or pressure
• Pain in arms, jaw, neck, back
• Breathing problems
• Severe stomach pain
• Blood clot formation
• Blood in stools or coughing blood
• Liver problems
• Yellowish discoloration of skin
How To Use
Lenvabuzz 4mg Capsule is an oral medication that is usually taken once a day, at approximately the same time each day, with or without food. It should be taken as prescribed by a doctor or other healthcare provider. The dose will be decided by the physician based on your age, weight and severity of the condition you are being treated with. These capsules should be swallowed whole with a glass of water. They should not be crushed, chewed, or opened, as this can affect the way the medication is absorbed and decrease its effectiveness. You should not take a double dose to make up for the second dose.
Safety Advice
• Breast Feeding: It is not recommended to take Lenvabuzz 4mg Capsule while nursing a child because it may pass through breast milk and cause potential harm to the baby.
• Alcohol: Both alcohol and Lenvabuzz 4mg Capsule are primarily metabolised in the liver and consuming alcohol can increase the chance of developing liver toxicity.
• Liver: Patients with pre-existing lung illnesses may be at higher risk of experiencing pulmonary problems while using Lenvabuzz 4mg Capsule. Consult your doctor if you have lung disease before starting the treatment.
• Lungs: Inform your doctor if you have liver disease because Lenvabuzz 4mg Capsule should be used cautiously with a liver condition. This medicine may also cause a rise in liver enzymes, which could indicate liver damage or inflammation. Patients using this drug must have regular blood tests to ensure that their liver function is checked.
• Driving: Patients receiving Lenvabuzz 4mg Capsule should be advised to avoid driving or operating machinery if they experience side effects such as fatigue, dizziness, or blurred vision, impairing a patient's ability to drive or operate machinery safely.
• Pregnancy: It is not recommended to take Lenvabuzz 4mg Capsule during pregnancy as it has the potential to cause foetal harm. Before beginning therapy with Lenvabuzz 4mg Capsule, tell your doctor if you are pregnant, suspect you are pregnant, or planning to become pregnant.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.